BioPharma Drug Discovery

Kindeva Drug Delivery Acquires Summit Biosciences, a Nasal Drug Development Specialist

The acquisition of Summit enhances Kindeva’s existing drug-delivery capabilities by adding a new drug-delivery platform, further expanding Kindeva&rs...

 January 19, 2024 | News and Project Data Sphere Merge Big Pharma Insights with Deep AI for Advancing Cancer Care

In a pivotal stride toward advancing cancer care,, a leader in artificial intelligence (AI) solutions for medical imaging, and Project Data Sp...

 January 19, 2024 | News

Australia Achieves Positive Results in Phase Ib Study for Androgenic Alopecia Treatment

This study is led by Professor Rodney Sinclair and included 12 male and 4 female patients in Australia with androgenic alopecia (AGA). ...

 January 15, 2024 | News

Japan Approves Neurolief's Relivion®, Paving the Way for At-Home Migraine Treatment.

Relivion® is a novel, non-invasive multi-channel brain neuromodulation technology. It stands out by concurrently stimulating the occipital and tri...

 January 12, 2024 | News

SyntheticGestalt and Enamine Partner for AI-Driven Drug Discovery Model

SyntheticGestalt, a research and development company specializing in the application of AI to the life sciences domain, and Enamine, the world's leading pr...

 January 11, 2024 | News

DNAnexus and Ovation Partner to Advance Drug Discovery with Precision Health Datasets

DNAnexus, Inc., the provider of the Precision Health Data Cloud, and Ovation, an omics data company committed to accelerating the development of preci...

 January 11, 2024 | News

Debiopharm and Partner for AI-Boosted Cancer Drug Development

Debiopharm, an independent biopharmaceutical company headquartered in Switzerland, and (TNL), a trailblazer in AI Digital Cells Lab in ...

 January 10, 2024 | News

OBI Pharma's partner Biosion announces FDA clearance for the Phase 1/2 study of OBI-992 (TROP2 ADC)

First clinical trial to evaluate the safety and efficacy of OBI-992 (a.k.a BSI-992), a novel antibody drug conjugate (ADC) targeting TROP2 - Dosing of f...

 January 09, 2024 | News

Novartis Partners with Isomorphic Labs to Pioneer AI-Driven Drug Discovery

Fiona H. Marshall, President of Biomedical Research at Novartis, expressed her excitement, stating, "We are entering into this collaboration with Isomorphi...

 January 08, 2024 | News

Akeso's Cadonilimab Granted NMPA Acceptance for First-Line Gastric Cancer Treatment.

This will be the second indication for which cadonilimab has received approval in China, following its use as a monotherapy treatment for recurrent or...

 January 08, 2024 | News

Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024

As we step into 2024, let's explore 15 AI companies at the forefront of this transformative journey. Atomwise: Revolutionizing Virtual Screening Atomw...

 December 27, 2023 | News

Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs

On December 20, NMPA has approved a clinical trial for JMKX003801 to treat serious infection caused by Gram-negative bacteria. Drug resistance of anti...

 December 27, 2023 | News

Innovent and SanegeneBio Collaborate on siRNA Drug for Hypertension Treatment

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

 December 27, 2023 | News

Oncoshot Collaborates with Zhejiang Ablaze for Data-Driven Drug Development in China

This collaboration brings together complementary strengths - Oncoshot's capabilities in data analysis and insights generation with Ablaze's recent expansio...

 December 26, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in